RIGEL PHARMACEUTICALS INC

Rigel Pharmaceuticals shares dipped 0.04% to $48.86, trading above its 200‑day average and up 1.52% month‑to‑date; compare its volatility to peers in biotech.

Rigel Pharmaceuticals (RIGL) gained ~2% in late‑November as investors eyed its clinical pipeline, showing steady gains amid a volatile biotech market.